Sugi Predict

Sugi Predict / Compounds / SCHEMBL19731887

SCHEMBL19731887

SCHEMBL19731887

CC(=O)NC1C(O)[C@H](O[C@@H]2OC(COO)[C@H](O)C(O)C2O)C(CO)O[C@H]1OC1C(O)[C@@H](O[C@@H]2OC(CO)[C@@H](O[C@@H]3OC(COO)[C@H](O)C(O)C3O)C(O)C2NC(C)=O)C(CO)O[C@H]1OC1C(O)[C@H](O[C@@H]2C(CO)O[C@@H](O[C@@H]3C(CO)O[C@@H](OCCCCCN)C(NC(C)=O)C3O)C(NC(C)=O)C2O)OC(CO[C@H]2OC(CO)[C@@H](O)[C@H](O)C2O[C@@H]2OC(CO)[C@@H](O[C@@H]3OC(CO)[C@H](O)C(O)C3O)C(O)C2NC(C)=O)[C@H]1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 2/20 0.62
▸ LGALS3 P17931 2/20 0.62
▸ LGALS4 P56470 2/20 0.62
▸ MAPK1 P28482 1/20 0.49
▸ CD209 Q9NNX6 2/20 0.49
▸ BMP2 P12643 3/20 0.48
▸ VEGFA P15692 3/20 0.48
▸ IFNG P01579 2/20 0.48
▸ FGF1 P05230 1/20 0.48
▸ FGF2 P09038 1/20 0.48
▸ SFRP1 Q8N474 1/20 0.48
▸ IGF2R P11717 2/20 0.43
▸ ENGASE Q8NFI3 1/20 0.43
▸ CXCL12 P48061 2/20 0.43
▸ SHH Q15465 2/20 0.43
▸ PF4 P02776 1/20 0.43
▸ CCL2 P13500 1/20 0.43
▸ SELP P16109 1/20 0.43
▸ BMP6 P22004 1/20 0.43
▸ CCL11 P51671 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18619720 0.93 LGALS3 (0.71) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL21179890 0.92 LGALS3 (0.70) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19726153 0.89 LGALS3 (0.60) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19726162 0.88 LGALS3 (0.61) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19398457 0.88 LGALS8 (0.65) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19404388 0.88 LGALS8 (0.65) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19404390 0.88 LGALS8 (0.65) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19726156 0.87 LGALS3 (0.60) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19726158 0.87 LGALS3 (0.57) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL18620664 0.86 LGALS8 (0.67) LGALS8LGALS3LGALS4MAPK1CD209

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336784-B2 Methods for modular synthesis of N-glycans and arrays thereof ACADEMIA SINICA (TW) 2019-07-02 — — US disclosed
US-20170362265-A1 METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF ACADEMIA SINICA (TW) 2017-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362265-A1 METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF SIGLEC7, SIGLEC9, CD4 LGALS8 49/4885LGALS3 52/4885LGALS4 37/4885
US-10336784-B2 Methods for modular synthesis of N-glycans and arrays thereof SIGLEC7, SIGLEC9, CD4 LGALS8 49/4885LGALS3 52/4885LGALS4 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.